|1.||Kuppusamy, Periannan: 1 article (02/2008)|
|2.||Sen, Chandan K: 1 article (02/2008)|
|3.||Ojha, Navdeep: 1 article (02/2008)|
|4.||Khanna, Savita: 1 article (02/2008)|
|5.||Biswas, Sabyasachi: 1 article (02/2008)|
|6.||Velayutham, Murugesan: 1 article (02/2008)|
|7.||Roy, Sashwati: 1 article (02/2008)|
|8.||He, Guanglong: 1 article (02/2008)|
|9.||Zweier, Jay L: 1 article (02/2008)|
|10.||Serraino, Ivana: 1 article (12/2002)|
12/01/2002 - "TEMPONE significantly improved both glomerular and tubular function (serum urea, creatinine, creatinine clearance, and fractional excretion of Na(+)) in a dose-dependent manner and significantly attenuated the reperfusion-injury associated with I/R (urinary N-acetyl-beta-D-glucosaminidase, aspartate aminotransferase, assessment of renal histology). "
12/01/2002 - "Here we investigate the effects of the stable, water-soluble nitroxyl radical, TEMPONE, on renal dysfunction and injury caused by ischemia/reperfusion (I/R) of the rat kidney in vivo. "
01/01/1997 - "Measurement of extracellular oxygen concentration during myocardial ischemia by spin label oximetry has been limited by ischemia-induced reduction of the neutral, water-soluble nitroxide TEMPONE. "
|3.||Myocardial Ischemia (Ischemic Heart Diseases)
|4.||Wounds and Injuries (Trauma)
|5.||Photosensitivity Disorders (Photodermatitis)
|3.||Aspartate Aminotransferases (Aspartate Transaminase)
|5.||Oxidants (Oxidizing Agents)